BAILLIE GIFFORD & CO

Holdings History for Denali Therapeutics Inc. - Common Stock (DNLI)

Symbol: DNLI on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock
Latest Disclosed Ownership: 12.3M shares
Security Ownership: 8.6%

Shares, Excluding Options vs Price

Value, Excluding Options

BAILLIE GIFFORD & CO ownership in Denali Therapeutics Inc. Common Stock (DNLI)

2025-02-12 - BAILLIE GIFFORD & CO has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12.3M shares of Denali Therapeutics Inc. Common Stock (DNLI). This represents 8.6% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BAILLIE GIFFORD & CO	8.6%		$196M	12.3M			$15.95	13G/A	12/31/2024	12 Feb 2025 10:52:00
BAILLIE GIFFORD & CO	7.2%		$43.7M	2.74M			$15.95	13G/A	12/31/2024	12 Feb 2025 10:55:07

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.19%	-0.02%	$251M	12.3M	-1,031,956	-7.73%	$20.38	Q4 2024
9/30/2024	0.29%	-0.01%	$389M	13.3M	-417,709	-3.03%	$29.13	Q3 2024
6/30/2024	0.25%	-0.01%	$320M	13.8M	-277,632	-1.98%	$23.22	Q2 2024
3/31/2024	0.22%	0%	$288M	14M	-219,496	-1.54%	$20.52	Q1 2024
12/31/2023	0.24%	-0.01%	$306M	14.3M	-420,303	-2.86%	$21.46	Q4 2023
9/30/2023	0.28%	0%	$303M	14.7M	-162,743	-1.1%	$20.63	Q3 2023
6/30/2023	0.37%	-0.01%	$438M	14.8M	-508,341	-3.31%	$29.51	Q2 2023
3/31/2023	0.32%	+0%	$354M	15.4M	+232,637	+1.54%	$23.04	Q1 2023
12/31/2022	0.44%	+0.01%	$420M	15.1M	+404,423	+2.75%	$27.81	Q4 2022
9/30/2022	0.47%	0%	$452M	14.7M	-154,323	-1.04%	$30.69	Q3 2022
6/30/2022	0.45%	0%	$438M	14.9M	-111,058	-0.74%	$29.43	Q2 2022
3/31/2022	0.34%	0%	$482M	15M	-75,949	-0.5%	$32.17	Q1 2022
12/31/2021	0.37%	+0%	$672M	15.1M	+46,565	+0.31%	$44.60	Q4 2021
9/30/2021	0.4%	0%	$757M	15M	-137,797	-0.91%	$50.45	Q3 2021
6/30/2021	0.58%	+0.09%	$1.19B	15.1M	+2,152,416	+16.6%	$78.44	Q2 2021
3/31/2021	0.42%	+0.03%	$742M	13M	+804,941	+6.6%	$57.10	Q1 2021
12/31/2020	0.57%	+0.06%	$1.02B	12.2M	+1,363,078	+12.6%	$83.76	Q4 2020
9/30/2020	0.27%	+0.04%	$388M	10.8M	+1,547,984	+16.7%	$35.83	Q3 2020
6/30/2020	0.17%	+0%	$224M	9.28M	+149,442	+1.64%	$24.18	Q2 2020
3/31/2020	0.17%	+0.03%	$160M	9.13M	+1,539,505	+20.3%	$17.51	Q1 2020
12/31/2019	0.13%	+0%	$132M	7.59M	+226,784	+3.08%	$17.42	Q4 2019
9/30/2019	0.13%	0%	$113M	7.36M	-43,766	-0.59%	$15.32	Q3 2019
6/30/2019	0.16%	+0.03%	$154M	7.41M	+1,145,003	+18.3%	$20.76	Q2 2019
3/31/2019	0.16%	+0%	$145M	6.26M	+34,502	+0.55%	$23.22	Q1 2019
12/31/2018	0.17%	+0.02%	$129M	6.23M	+741,303	+13.5%	$20.66	Q4 2018
9/30/2018	0.13%	+0%	$119M	5.49M	+141,788	+2.65%	$21.74	Q3 2018
6/30/2018	0.09%	+0%	$81.5M	5.34M	+151,787	+2.92%	$15.25	Q2 2018
3/31/2018	0.12%	+0.01%	$102M	5.19M	+271,063	+5.51%	$19.69	Q1 2018
12/31/2017	0.1%	+0.1%	$77M	4.92M	+4,921,783	NEW	$15.64	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.